Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04933851 · ClinicalTrials.gov registry record · Phase 2
ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes
A Phase 2 study of Type 1 Diabetes, sponsored by Scripps Whittier Diabetes Institute.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT04933851 is a Phase 2 study of Type 1 Diabetes that is actively recruiting participants, run by Scripps Whittier Diabetes Institute. The registered enrollment target is 250 participants, below the 823-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04933851, a Phase 2 study of Type 1 Diabetes, is actively recruiting participants, sponsored by Scripps Whittier Diabetes Institute.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
This research will compare a psychological intervention ("ACT1VATE") versus diabetes self-management education and support (DSME/S; usual care) in improving clinical, behavioral, psychosocial, process, and cost outcomes among adults with poorly controlled type 1 diabetes (T1D) who are experiencing significant diabetes-related emotional distress and poor glycemic control in a real world, healthcare environment.
Conditions Studied
Interventions
- BEHAVIORAL ACT1VATE
- BEHAVIORAL DSME/S
Study Locations (1)
California
- Scripps Whittier Diabetes Institute - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2021-10-25 |
| Est. Completion | 2027-03-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04933851
The ClinicalTrials.gov registry entry for NCT04933851 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 823-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (70% lower). The listed sponsor is Scripps Whittier Diabetes Institute, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which ACT1VATE is the first listed.
NCT04933851 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04933851 about?
NCT04933851 is a clinical study titled "ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes". This research will compare a psychological intervention ("ACT1VATE") versus diabetes self-management education and support (DSME/S; usual care) in improving clinical, behavioral, psychosocial, process, and cost outcomes among adults with poorly controlled type 1 diabetes (T1D) who are experiencing s...
What is the current status of trial NCT04933851?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 250 participants. The study started on 2021-10-25. Estimated completion is 2027-03-31.
What conditions does trial NCT04933851 study?
This clinical trial studies the following conditions: Type 1 Diabetes.
What interventions are being tested in trial NCT04933851?
The interventions under investigation include: ACT1VATE (BEHAVIORAL), DSME/S (BEHAVIORAL).
Who is sponsoring clinical trial NCT04933851?
This trial is sponsored by Scripps Whittier Diabetes Institute, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04933851 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Precision Administration of Anti-thymocyte Globulin With or Without Verapamil
RECRUITING · Phase 2
-
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
RECRUITING · Phase 2
-
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
RECRUITING · Phase 2
-
Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes
RECRUITING · Phase 2
-
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
RECRUITING · Phase 2
-
TArgeting Type 1 Diabetes Using POLyamines (TADPOL)
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.